Literature DB >> 7065268

Dependence of 13NH3 myocardial extraction and clearance on flow and metabolism.

J Krivokapich, S C Huang, M E Phelps, N S MacDonald, K I Shine.   

Abstract

The isolated arterially perfused rabbit interventricular septum was used to study the relationship between flow (F) and myocardial uptake and subsequent clearance of bolus injections of 13N-labeled ammonia (13NH3). Multiple 13NH3 injections were delivered to a total of 19 septa at perfusion rates (F/g) ranging from 0.2-4.0 ml.min-1.g-1. Ten septa were studied at 37 degrees C and nine were studied at 28 degrees C to obtain uptake and clearance data at different metabolic rates. The septa were perfused without recirculation with a modified Tyrode solution. Analysis of the time-activity curves generated by the injections of 13NH3 revealed that the data was best described by three components. The first two components exhibited short clearance times (t1/2s less than 7 min) in contrast to prolonged clearance times (30-500 min) for component 3. Component 1 was consistent with a freely diffusible 13NH3 compartment. Component 3 persists and permits myocardial imaging 15 min or more after 13NH3 injection. At each perfusion rate the extraction fraction of component 3 was twice as large, and the clearance time of component 3 was twice as fast at 37 as at 28 degrees C, implying that the extraction and washout of this third component are dependent on enzymatic reactions. The total myocardial extraction into component 3 from a systemic injection is determined by multiplying the extraction fraction by the perfusion rate (EF(3) X F/g) and was directly related to the perfusion rate at both 28 and 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065268     DOI: 10.1152/ajpheart.1982.242.4.H536

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Clinical methods to determine coronary flow and myocardial perfusion.

Authors:  M J Wolters-Geldof; V M Cats; A V Bruschke
Journal:  Int J Card Imaging       Date:  1997-04

Review 2.  Myocardial flow reserve (MFR) with positron emission tomography (PET)/computed tomography (CT): clinical impact in diagnosis and prognosis.

Authors:  Maria Cecilia Ziadi
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

3.  Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: comparison of 2 tracer kinetic models.

Authors:  Aliasghar Khorsand; Senta Graf; Christian Pirich; Otto Muzik; Kurt Kletter; Robert Dudczak; Gerald Maurer; Heinz Sochor; Ernst Schuster; Gerold Porenta
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

Review 4.  [Examination of myocardial perfusion with positron emission tomography: a clinically useful and valid method?].

Authors:  J vom Dahl
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

Review 5.  Cardiac PET perfusion tracers: current status and future directions.

Authors:  Jamshid Maddahi; René R S Packard
Journal:  Semin Nucl Med       Date:  2014-09       Impact factor: 4.446

6.  An improved model for the measurement of myocardial perfusion in human beings using N-13 ammonia.

Authors:  Kathleen T Hickey; Robert R Sciacca; Ru-Ling Chou; Oswaldo Rodriguez; Sabahat Bokhari; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

7.  Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: comparison with rubidium 82 and copper 62-labeled PTSM.

Authors:  R S Beanlands; O Muzik; G D Hutchins; E R Wolfe; M Schwaiger
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

Review 8.  Advanced tracers in PET imaging of cardiovascular disease.

Authors:  Yesen Li; Wei Zhang; Hua Wu; Gang Liu
Journal:  Biomed Res Int       Date:  2014-10-15       Impact factor: 3.411

9.  Radiopharmaceutical tracers for cardiac imaging.

Authors:  Osamu Manabe; Tatsuya Kikuchi; Arthur J H A Scholte; Mohammed El Mahdiui; Ryuichi Nishii; Ming-Rong Zhang; Eriko Suzuki; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2017-12-01       Impact factor: 5.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.